Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Diagnos Inc

ADK.V ✓ COMPLIANT ☆ Track — members

TSX Venture · Technology · IT Services & Consulting ·

Canada Micro Cap Analyst: N/A

Last Close

$0.34

▼ -1.04%

Market Cap $41.69M · Vol 61.73K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$41.69M

Micro Cap

Div Yield

N/A

Dividend with no set frequency

EPS Growth

N/A

YoY

RSI (14)

70.51

Momentum

Beta

0.05

vs Market

52W High

$0.38

8.23% below

52W Low

$0.13

171.10% above

Volume

61.73K

Avg 372.92K

P/B

48.21

Price-to-book

ROE

N/A

Return on equity

Free Float

94.41%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Diagnos Inc (ADK.V) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ADK.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-5.00%

+58.33%

+111.11%

+53.23%

YTD

+26.67%

+72.73%

-6.35%

-6.86%

Financials & Valuation

TTM · Annual

Total Revenue	$47.06K
Net Income	$-3,273,825.00
Revenue Growth (YoY)	-14.58%
Gross Margin	15.29%
Operating Margin	-6,510.52%
Net Profit Margin	-6,956.84%
ROE	N/A
ROA · ROIC	-151.17% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	453.08
P/B	48.21
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	121.04M

Technical Indicators

50-Day SMA	$0.24
200-Day SMA	$0.21
RSI (14)	70.51
Beta	0.05
52-Week High	$0.38
52-Week Low	$0.13

Volume Today	61.73K
Avg Daily Volume (30D)	372.92K
Relative Volume	0.17x
Volatility (10D)	73.84
Volatility (30D)	85.99
Free Float	94.41%

Analyst Consensus

N/A

Current Price $0.34

Mean Target N/A

52W Low$0.13 52W High$0.38

Current

Target

$0.13 $0.38

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX Venture

FIGIBBG001S5NM65

ISINCA2524423068

CountryCanada

Sub-IndustryIT Services & Consulting (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

IBM International Business Machines Corp +0.08% SNOW Snowflake Inc -5.41% ACN Accenture PLC -3.31% TCS.NS Tata Consultancy Services Ltd -0.69% RELX Relx PLC -3.11%

Company Profile

Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.